Fraser, G. L., Lederman, S., Waldbaum, A., Kroll, R., Santoro, N., Lee, M., . . . Ramael, S. (2020). A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause. Menopause.

Fraser, Graeme L., Samuel Lederman, Arthur Waldbaum, Robin Kroll, Nanette Santoro, Misun Lee, Laurence Skillern, und Steven Ramael. "A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study of the Neurokinin 3 Receptor Antagonist Fezolinetant for Vasomotor Symptoms Associated With Menopause." Menopause 2020.

Fraser, Graeme L., et al. "A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study of the Neurokinin 3 Receptor Antagonist Fezolinetant for Vasomotor Symptoms Associated With Menopause." Menopause 2020.